CERUS CORP (CERS) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 34 days, typically, give or take 11 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Mon, Nov 2, 2026after close 33 8-K
Q2 FY2026Thu, Jul 30, 2026after close 30 8-K
Q1 FY2026Thu, Apr 30, 2026after close 30 8-K
Q4 FY2025Mon, Mar 2, 2026after close 61 8-K
Q3 FY2025Thu, Nov 6, 2025after close 37 8-K
Q2 FY2025Tue, Aug 5, 2025after close 36 8-K
Q1 FY2025Thu, May 1, 2025after close 31 8-K
Q4 FY2024Thu, Feb 20, 2025after close 51 8-K

What they guided beta

Q3 FY2026 "Reiterating Full-Year 2026 Product Revenue Guidance" exhibit
Q3 FY2026 "The Company continues to expect full-year 2026 product revenue to be in the range of $229 million to $231 million, reflecting growth of 11% to 12% from 2025." exhibit
Q3 FY2026 "Included in this range is full-year 2026 IFC revenue guidance of $23 million to $25 million." exhibit
Q3 FY2026 "A replay will be available on Cerus’ website approximately three hours after the call through November 23, 2026. *FC15 equivalent to a therapeutic dose of a cryoAHF pool." exhibit
Q3 FY2026 "Cerus anticipates or at all; risks associated with macroeconomic developments, including the ongoing military conflict in Ukraine and the ongoing military conflict involving Iran, the U.S. and Israel, new or increased tariffs and escalating trade tensions, inflation, rising interest rates and foreign exchange volatility and the resulting global economic and financial disruptions; risks related to Cerus’ ability to demonstrate to the transfusion medicine community and other healthcare constituencies that pathogen reduction and the INTERCEPT Blood System are safe, effective and economical; risks" exhibit
Q2 FY2026 "Raising Lower End of 2026 Product Revenue" exhibit
Q2 FY2026 "Guidance: Range now $229 to $231 million; Raising 2026 IFC Sales Outlook to $23 to $25 million, up approximately 40% to 50% Y/Y" exhibit
Q2 FY2026 "Cash use in operations in the second quarter of 2026 was tied to an increase in working capital, namely inventory in support of the expected growth." exhibit
Q2 FY2026 "Narrowing And Raising Low End of 2026 Product Revenue Guidance The Company now expects full-year 2026 product revenue to be in the range of $229 million to $231 million, reflecting growth of 11% to 12% from 2025." exhibit
Q2 FY2026 "Included in this range is increased full-year 2026 IFC revenue guidance of $23 million to $25 million." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/CERS
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/CERS

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

CERS earnings date badge

HTML

<a href="https://veritasdata.dev/company/CERS/"><img src="https://veritasdata.dev/embed/CERS.svg" alt="CERS earnings date" width="240" height="56"></a>

Markdown

[![CERS earnings date](https://veritasdata.dev/embed/CERS.svg)](https://veritasdata.dev/company/CERS/)

Script

<script async src="https://veritasdata.dev/embed/CERS.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/CERS"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.